Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MLND - Millendo Therapeutics Inc

Previous close
1.06
0   0%

Share volume: 0
Last Updated: Fri 25 Jun 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$1.06
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 43%
Dept financing 6%
Liquidity 47%
Performance 28%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-30.26%
1 Month
-7.02%
3 Months
-51.38%
6 Months
-53.30%
1 Year
-41.44%
2 Year
-90.48%
Key data
Stock price
$1.06
P/E Ratio 
0.00
DAY RANGE
$1.06 - $1.13
EPS 
$0.00
52 WEEK RANGE
$0.92 - $2.77
52 WEEK CHANGE
$0.00
MARKET CAP 
20.186 M
YIELD 
N/A
SHARES OUTSTANDING 
19.043 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.03
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,666,333
AVERAGE 30 VOLUME 
$3,181,754
Company detail
CEO:
Region: US
Website: www.millendo.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

Recent news